MX2018006283A - Composiciones bacterianas diseñadas. - Google Patents
Composiciones bacterianas diseñadas.Info
- Publication number
- MX2018006283A MX2018006283A MX2018006283A MX2018006283A MX2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A
- Authority
- MX
- Mexico
- Prior art keywords
- bacterial compositions
- designed bacterial
- designed
- compositions
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporcionan composiciones y métodos para tratar disbiosis gastrointestinal mediante el uso de una cantidad limitada de especies bacterianas definidas.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562259523P | 2015-11-24 | 2015-11-24 | |
US201662351696P | 2016-06-17 | 2016-06-17 | |
US201662401011P | 2016-09-28 | 2016-09-28 | |
PCT/US2016/063697 WO2017091783A2 (en) | 2015-11-24 | 2016-11-23 | Designed bacterial compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018006283A true MX2018006283A (es) | 2019-09-06 |
Family
ID=57614452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018006283A MX2018006283A (es) | 2015-11-24 | 2016-11-23 | Composiciones bacterianas diseñadas. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20190247447A1 (es) |
EP (2) | EP4233884A3 (es) |
JP (2) | JP2019501136A (es) |
KR (1) | KR20180083894A (es) |
CN (1) | CN109661236A (es) |
AU (2) | AU2016359178A1 (es) |
BR (1) | BR112018010430A2 (es) |
CA (1) | CA3006187A1 (es) |
DK (1) | DK3380108T3 (es) |
ES (1) | ES2938361T3 (es) |
FI (1) | FI3380108T3 (es) |
MX (1) | MX2018006283A (es) |
PL (1) | PL3380108T3 (es) |
PT (1) | PT3380108T (es) |
WO (1) | WO2017091783A2 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
EP2951285A4 (en) | 2013-02-04 | 2016-10-26 | Seres Therapeutics Inc | COMPOSITIONS AND METHODS FOR INHIBITING THE GROWTH OF PATHOGENIC BACTERIA |
EP2967077A4 (en) | 2013-03-15 | 2016-09-14 | Seres Therapeutics Inc | MICROBIAL COMPOSITIONS AND ASSOCIATED METHODS BASED ON A NETWORK |
AU2014352643A1 (en) | 2013-11-25 | 2016-06-30 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
GB2551642B (en) | 2014-10-31 | 2020-09-23 | Pendulum Therapeutics Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
US9999641B2 (en) | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
US11959125B2 (en) * | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
WO2018187272A1 (en) | 2017-04-03 | 2018-10-11 | Gusto Global, Llc | Rational design of microbial-based biotherapeutics |
PL3600364T3 (pl) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Kompozycje zawierające szczep bakteryjny z rodzaju megasphaera i ich zastosowania |
EP3642325A1 (en) * | 2017-06-22 | 2020-04-29 | President and Fellows of Harvard College | Inhibition of colonic group 3 innate lymphoid cells |
US11865145B2 (en) | 2017-08-07 | 2024-01-09 | Finch Therapeutics Holdings Llc | Compositions and methods for maintaining and restoring a healthy gut barrier |
RU2020110462A (ru) | 2017-08-14 | 2021-09-16 | Серес Терапеутикс, Инк. | Композиции и способы для лечения холестатического заболевания |
WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
KR20200065022A (ko) * | 2017-10-03 | 2020-06-08 | 세레스 테라퓨틱스, 인코포레이티드 | 트립타민 대사의 조작 |
US20200353018A1 (en) * | 2017-10-30 | 2020-11-12 | Seres Therapeutics, Inc. | Compositions and methods for treating antibiotic resistance |
WO2019169143A1 (en) * | 2018-02-28 | 2019-09-06 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer using turicibacter sanguinis |
US20210121505A1 (en) * | 2018-03-29 | 2021-04-29 | Seres Therapeutics, Inc. | Compositions and methods for treating inflammatory bowel diseases |
EP3773642A4 (en) | 2018-04-13 | 2022-03-02 | White Dog Labs, Inc. | IMPROVED METHOD OF SELECTING PROBIOTICS |
JP2021523895A (ja) | 2018-05-11 | 2021-09-09 | フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited | 細菌株を含む組成物 |
CA3101184A1 (en) * | 2018-05-24 | 2019-11-28 | Seres Therapeutics, Inc. | Designed bacterial compositions and uses thereof |
WO2020002370A1 (en) * | 2018-06-25 | 2020-01-02 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
KR20200021257A (ko) | 2018-08-20 | 2020-02-28 | 아주대학교산학협력단 | 유박테리움 렉탈레를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물 |
JP7451185B2 (ja) | 2019-01-22 | 2024-03-18 | 株式会社ダイセル | 新規微生物およびその利用 |
KR102379022B1 (ko) * | 2019-05-24 | 2022-03-28 | 주식회사 엠디헬스케어 | qPCR 분석을 통한 위암 진단방법 |
CN112481395A (zh) * | 2019-09-12 | 2021-03-12 | 深圳华大生命科学研究院 | 艰难梭菌耐药/低敏感进化分支snp标记及菌株类别鉴定方法和应用 |
CA3159711A1 (en) * | 2019-11-27 | 2021-06-03 | Asuncion Martinez | Designed bacterial compositions and uses thereof |
EP3838281A1 (en) * | 2019-12-20 | 2021-06-23 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
KR20230088680A (ko) | 2020-08-14 | 2023-06-20 | 프롤랙타 바이오사이언스, 인코포레이티드 | 박테리아 요법에 사용하기 위한 인간 모유 올리고당 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201704035TA (en) * | 2012-11-23 | 2017-06-29 | Seres Therapeutics Inc | Synergistic bacterial compositions and methods of production and use thereof |
US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US10973861B2 (en) * | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
EP2951285A4 (en) * | 2013-02-04 | 2016-10-26 | Seres Therapeutics Inc | COMPOSITIONS AND METHODS FOR INHIBITING THE GROWTH OF PATHOGENIC BACTERIA |
AU2014352643A1 (en) * | 2013-11-25 | 2016-06-30 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US9956282B2 (en) * | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
-
2016
- 2016-11-23 FI FIEP16819219.3T patent/FI3380108T3/fi active
- 2016-11-23 CA CA3006187A patent/CA3006187A1/en active Pending
- 2016-11-23 PL PL16819219.3T patent/PL3380108T3/pl unknown
- 2016-11-23 BR BR112018010430A patent/BR112018010430A2/pt not_active Application Discontinuation
- 2016-11-23 US US15/778,095 patent/US20190247447A1/en active Pending
- 2016-11-23 JP JP2018526790A patent/JP2019501136A/ja active Pending
- 2016-11-23 MX MX2018006283A patent/MX2018006283A/es unknown
- 2016-11-23 WO PCT/US2016/063697 patent/WO2017091783A2/en active Application Filing
- 2016-11-23 CN CN201680079256.3A patent/CN109661236A/zh active Pending
- 2016-11-23 EP EP22207065.8A patent/EP4233884A3/en active Pending
- 2016-11-23 DK DK16819219.3T patent/DK3380108T3/da active
- 2016-11-23 EP EP16819219.3A patent/EP3380108B1/en active Active
- 2016-11-23 PT PT168192193T patent/PT3380108T/pt unknown
- 2016-11-23 AU AU2016359178A patent/AU2016359178A1/en not_active Abandoned
- 2016-11-23 KR KR1020187016523A patent/KR20180083894A/ko not_active Application Discontinuation
- 2016-11-23 ES ES16819219T patent/ES2938361T3/es active Active
-
2021
- 2021-12-02 JP JP2021196351A patent/JP2022033885A/ja active Pending
-
2024
- 2024-02-02 AU AU2024200663A patent/AU2024200663A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN109661236A (zh) | 2019-04-19 |
ES2938361T3 (es) | 2023-04-10 |
AU2024200663A1 (en) | 2024-02-22 |
US20190247447A1 (en) | 2019-08-15 |
EP4233884A2 (en) | 2023-08-30 |
PT3380108T (pt) | 2023-02-17 |
KR20180083894A (ko) | 2018-07-23 |
CA3006187A1 (en) | 2017-06-01 |
AU2016359178A1 (en) | 2018-06-14 |
EP4233884A3 (en) | 2023-10-04 |
JP2019501136A (ja) | 2019-01-17 |
EP3380108B1 (en) | 2022-11-16 |
BR112018010430A2 (pt) | 2018-11-27 |
FI3380108T3 (fi) | 2023-03-03 |
EP3380108A2 (en) | 2018-10-03 |
RU2018122664A (ru) | 2019-12-25 |
RU2018122664A3 (es) | 2020-04-15 |
PL3380108T3 (pl) | 2023-03-27 |
DK3380108T3 (da) | 2023-02-06 |
JP2022033885A (ja) | 2022-03-02 |
WO2017091783A2 (en) | 2017-06-01 |
WO2017091783A3 (en) | 2017-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018006283A (es) | Composiciones bacterianas diseñadas. | |
MX2021000710A (es) | Composiciones que comprenden cepas bacterianas. | |
HK1243640A1 (zh) | 用於治療潰瘍的方法和組合物 | |
TW201613966A (en) | SynTac polypeptides and uses thereof | |
IL262258A (en) | A new bacterial species | |
MX2017016529A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2017016398A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2017016560A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2017016525A (es) | Composiciones que comprenden cepas bacterianas. | |
HK1249432A1 (zh) | 治療細菌感染的方法 | |
EP3209298A4 (en) | Compositions and methods for treating insomnia | |
EP3408344A4 (en) | METHOD AND COMPOSITIONS FOR BORING TREATMENT | |
GB2553919B (en) | Biomass treatment apparatus | |
EP3268010A4 (en) | Compositions and methods for treating bacterial infection | |
MX2018000291A (es) | Metodos para tratar la colitis. | |
PH12017501864A1 (en) | Compositions and methods for treating autism | |
IL291266A (en) | Preparations and methods for treating infections | |
MX2016009537A (es) | Metodo para tratar ropa. | |
HK1221604A1 (zh) | 豬苓菌與蜜環菌屬的種的共生方法及使用該方法的豬苓菌的栽培方法 | |
EP3190893A4 (en) | Compositions and methods for treating and preventing bacterial infections | |
HK1254232A1 (zh) | 用於治療胃潰瘍的方法和組合物 | |
MY167350A (en) | Fat-and-oil composition and chocolate | |
EP3139744A4 (en) | Methods and compositions for treating and preventing tinnitus | |
ZA201606811B (en) | Compositions and methods for identifying ehrlichia species | |
MX2016009541A (es) | Metodo para tratar vajilla. |